ClinicalTrials.Veeva

Menu

Systematic IPP VS Symptomatic IPP in GERD Prevention After POEM for Achalasia. . A Comparative Retrospective Analysis (IPPOEM-Retro)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Achalasia
Gastroesophageal Reflux

Study type

Observational

Funder types

Other

Identifiers

NCT04740437
RECHMPL21_0064

Details and patient eligibility

About

POEM is a minimally invasive endoscopic therapy that is highly efficacy in the treatment of achalasia of any type. POEM has an increased risk of GERD. Systematic PPI therapy has never been studied for the prevention of post-POEM GERD.

The investigators wish to retrospectively compare patients who have received routine PPI therapy vs. patients who don't.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years old
  • Consent given
  • Achalasia all types with eckhardt score > 3

Exclusion criteria

  • Patient who is a minor or under judicial protection
  • Pregnant or breastfeeding woman
  • Contraindication to PPIs
  • Carrier of mediastinal and exogastric neoplasia
  • Patient on PPIs prior to the procedure for indication that does not allow for their discontinuation
  • Peptic esophagitis (Grade B, C or D) before or at the time of the procedure
  • Previous treatment with Heller myotomy

Trial contacts and locations

1

Loading...

Central trial contact

Mathilde Charrier, MD; Antoine Debourdeau, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems